参考文献
1: Getlik M, Smil D, Zepeda-Velázquez C, Bolshan Y, Poda G, Wu H, Dong A,
Kuznetsova E, Marcellus R, Senisterra G, Dombrovski L, Hajian T, Kiyota T,
Schapira M, Arrowsmith CH, Brown PJ, Vedadi M, Al-Awar R. Structure-Based
Optimization of a Small Molecule Antagonist of the Interaction Between WD
Repeat-Containing Protein 5 (WDR5) and Mixed-Lineage Leukemia 1 (MLL1). J Med
Chem. 2016 Mar 24;59(6):2478-96. doi: 10.1021/acs.jmedchem.5b01630. Epub 2016 Mar
9. PubMed PMID: 26958703.
2: Grebien F, Vedadi M, Getlik M, Giambruno R, Grover A, Avellino R, Skucha A,
Vittori S, Kuznetsova E, Smil D, Barsyte-Lovejoy D, Li F, Poda G, Schapira M, Wu
H, Dong A, Senisterra G, Stukalov A, Huber KV, Schönegger A, Marcellus R, Bilban
M, Bock C, Brown PJ, Zuber J, Bennett KL, Al-Awar R, Delwel R, Nerlov C,
Arrowsmith CH, Superti-Furga G. Pharmacological targeting of the Wdr5-MLL
interaction in C/EBPα N-terminal leukemia. Nat Chem Biol. 2015 Aug;11(8):571-8.
doi: 10.1038/nchembio.1859. Epub 2015 Jul 13. Erratum in: Nat Chem Biol. 2015
Oct;11(10):815. PubMed PMID: 26167872; PubMed Central PMCID: PMC4511833.
